Müllerian inhibiting substance type II receptor (MISIIR): A novel, tissue-specific target expressed by gynecologic cancers

Jamie N. Bakkum-Gamez, Giovanni Aletti, Kriste A. Lewis, Gary L. Keeney, Bijoy M. Thomas, Isabelle Navarro-Teulon, William A. Cliby

Research output: Contribution to journalArticlepeer-review

42 Scopus citations

Fingerprint Dive into the research topics of 'Müllerian inhibiting substance type II receptor (MISIIR): A novel, tissue-specific target expressed by gynecologic cancers'. Together they form a unique fingerprint.

Medicine & Life Sciences